These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27280389)

  • 1. Is preemptive antifungal therapy a good alternative to empirical treatment in prolonged febrile neutropenia?
    Koch E; Rada G
    Medwave; 2016 Jun; 16 Suppl 2():e6463. PubMed ID: 27280389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer.
    Uneno Y; Imura H; Makuuchi Y; Tochitani K; Watanabe N
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013604. PubMed ID: 36440894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial.
    Santolaya ME; Alvarez AM; Acuña M; Avilés CL; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Zubieta M; Farfán M; de la Maza V; Vergara A; Valenzuela R; Torres JP
    J Antimicrob Chemother; 2018 Oct; 73(10):2860-2866. PubMed ID: 30010931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).
    Boğa C; Bolaman Z; Çağırgan S; Karadoğan İ; Özcan MA; Özkalemkaş F; Saba R; Sönmez M; Şenol E; Akan H; Akova M
    Turk J Haematol; 2015 Jun; 32(2):100-17. PubMed ID: 26316478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
    Fung M; Kim J; Marty FM; Schwarzinger M; Koo S
    PLoS One; 2015; 10(11):e0140930. PubMed ID: 26554923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta-analysis on the Influence of Antifungal Spectrum on Effectiveness of Empirical Antifungal Therapy for Febrile Neutropenia].
    Irikuchi J; Imai T; Tanaka M; Tanuma M; Orii T; Kato T
    Yakugaku Zasshi; 2017; 137(9):1117-1127. PubMed ID: 28867698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review on efficacy and safety of empirical versus pre-emptive antifungal therapy among children with febrile neutropenia reveals paucity of data.
    Sachdeva M; Malik M; Pradhan P; Kaur K; Dogra S; Mathew JL
    Mycoses; 2024 Apr; 67(4):e13722. PubMed ID: 38606896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the addition of aminoglycosides to beta-lactams in cancer patients with febrile neutropenia needed?
    Contreras V; Sepúlveda S; Heredia A
    Medwave; 2016 Feb; 16 Suppl 1():e6379. PubMed ID: 26938974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis.
    Chen K; Wang Q; Pleasants RA; Ge L; Liu W; Peng K; Zhai S
    BMC Infect Dis; 2017 Feb; 17(1):159. PubMed ID: 28219330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China.
    Yuan W; Ren J; Guo X; Guo X; Cai S
    Med Sci Monit; 2016 Nov; 22():4226-4232. PubMed ID: 27819257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric antifungal therapy in patients with febrile neutropenia.
    Ferrara JJ; MacDougall C; Gallagher JC
    Pharmacotherapy; 2011 Apr; 31(4):369-85. PubMed ID: 21449626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
    Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y
    Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
    Jeong SH; Kim DY; Jang JH; Mun YC; Choi CW; Kim SH; Kim JS; Park JS
    Ann Hematol; 2016 Jan; 95(2):337-44. PubMed ID: 26596974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associazione Italiana Ematologia ed Oncologia Pediatrica, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Sorveglianza Epidemiologica delle Infezioni Fungine nelle Emopatie Maligne.
    Girmenia C; Aversa F; Busca A; Candoni A; Cesaro S; Luppi M; Pagano L; Rossi G; Venditti A; Nosari AM; ; ; ; ;
    Hematol Oncol; 2013 Sep; 31(3):117-26. PubMed ID: 23037867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia.
    Hahn-Ast C; Felder L; Mayer K; Mückter S; Ruhnke M; Hein R; Hellmich M; Schwab K; Rachow T; Brossart P; von Lilienfeld-Toal M
    Ann Hematol; 2016 May; 95(6):1001-9. PubMed ID: 27021301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
    Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
    Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
    J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of clinical trials of empiric antifungal therapy in patients with persistent febrile neutropenia: considerations and critiques.
    Sobel JD
    Pharmacotherapy; 2006 Jun; 26(6 Pt 2):47S-54S. PubMed ID: 16716122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies.
    Gea-Banacloche J
    Hematology Am Soc Hematol Educ Program; 2013; 2013():414-22. PubMed ID: 24319213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.